Suppression of 3-deoxyglucosone and heparin-binding epidermal growth factor-like growth factor mRNA expression by an aldose reductase inhibitor in rat vascular smooth muscle cells

Biochemical and Biophysical Research Communications

Volumn 314, Issue 2, 2004, Pages 370-376

  Li, Weiguo ^a   Hamada, Yoji ^a   Nakashima, Eitaro ^a   Naruse, Keiko ^a   Kamiya, Hideki ^a   Akiyama, Noboru ^a   Hirooka, Hiroko ^b   Takahashi, Naoki ^b   Horiuchi, Seikoh ^c   Hotta, Nigishi ^d   Oiso, Yutaka ^a   Nakamura, Jiro ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Drug Devmt Research Laboratories   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d CHUBU ROSAI HOSPITAL   (Japan)

Author keywords

3 Deoxyglucosone; Advanced glycation end products; Aldose reductase inhibitor; HB EGF; Polyol pathway; TBARS; Vascular smooth muscle cells

Indexed keywords

3 DEOXYGLUCOSONE; ADVANCED GLYCATION END PRODUCT; ALDOSE REDUCTASE INHIBITOR; AMINOGUANIDINE; CARBONYL DERIVATIVE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MESSENGER RNA; POLYOL; SORBITOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; GENE REPRESSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 9144233547     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.12.095     Document Type: Article

References (51)

1. Stamler J., Vaccaro O., Neaton J.D., Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 16:1993;434-444.
2. Raines E.W., Ross R. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br. Heart J. 69(Suppl. 1):1993;S30-S37.
3. Ross R. Rous-whipple award lecture. Atherosclerosis: a defense mechanism gone awry. Am. J. Pathol. 143:1993;987-1002.
4. Larson D.M., Haudenschild C.C. Activation of smooth muscle cell outgrowth from BB/Wor rat aortas. Diabetes. 37:1988;1380-1385.
5. Natarajan R., Gonzales N., Xu L., Nadler J.L. Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. Biochem. Biophys. Res. Commun. 187:1992;552-560.
6. Satoh H., Togo M., Hara M., Miyata T., Han K., Maekawa H., Ohno M., Hashimoto Y., Kurokawa K., Watanabe T. Advanced glycation endproducts stimulate mitogen-activated protein kinase and proliferation in rabbit vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 239:1997;111-115.
7. Reuf J., Hu Z.Y., Yin L.Y., Wu Y., Hanson S.R., Kelly A.B., Harker L.A., Rao G.N., Runge M.S., Patterson C. Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis. Circ. Res. 81:1997;24-33.
8. Wu L., Juurlink B.H. Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells. Hypertension. 39:2002;809-814.
9. Che W., Asahi M., Takahashi M., Kaneto H., Okado A., Higashiyama S., Taniguchi N. Selective induction of heparin-binding epidermal growth factor-like growth factor by methylglyoxal and 3-deoxyglucosone in rat aortic smooth muscle cells. The involvement of reactive oxygen species formation and a possible implication for atherogenesis in diabetes. J. Biol. Chem. 272:1997;18453-18459.
10. Iwamoto R., Mekada E. Heparin-binding EGF-like growth factor: a juxtacrine growth factor. Cytokine Growth Factor Rev. 11:2000;335-344.
11. Hamada Y., Araki N., Horiuchi S., Hotta N. Role of polyol pathway in nonenzymatic glycation. Nephrol. Dial. Transplant. 11(Suppl. 5):1996;95-98.
12. Tsukushi S., Katsuzaki T., Aoyama I., Takayama F., Miyazaki T., Shimokata K., Niwa T. Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: role of the polyol pathway. Kidney Int. 55:1999;1970-1976.
13. Giugliano D., Ceriello A., Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 19:1996;257-267.
14. Lee A.Y., Chung S.S. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J. 13:1999;23-30.
15. Van den Enden M.K., Nyengaard J.R., Ostrow E., Burgan J.H., Williamson J.R. Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism. Implications for diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 36:1995;1675-1685.
16. Szwergold B.S., Kappler F., Brown T.R. Identification of fructose 3-phosphate in the lens of diabetic rats. Science. 247:1990;451-454.
17. Yasunari K., Kohno M., Kano H., Yokokawa K., Horio T., Yoshikawa J. Aldose reductase inhibitor prevents hyperproliferation and hypertrophy of cultured rat vascular smooth muscle cells induced by high glucose. Arterioscler. Thromb. Vasc. Biol. 15:1995;2207-2212.
18. Kasuya Y., Nakamura J., Hamada Y., Nakayama M., Sasaki H., Komori T., Chaya S., Watanabe G., Naruse K., Nakashima E., Kato K., Hotta N. An aldose reductase inhibitor prevents the glucose-induced increase in PDGF-beta receptor in cultured rat aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 261:1999;853-858.
19. Gordon O.G., Wayne M.C. Determination of monosaccharides as aldononitrile, O -methyloxime, alditol, and cyclitol acetate derivatives by gas chromatography Anal. Chem. 56:1984;633-638.
20. Yamada H., Miyata S., Igaki N., Yatabe H., Miyauchi Y., Ohara T., Sakai M., Shoda H., Oimomi M., Kasuga M. Increase in 3-deoxyglucosone levels in diabetic rat plasma. Specific in vivo determination of intermediate in advanced Maillard reaction. J. Biol. Chem. 269:1994;20275-20280.
21. Horiuchi S., Araki N., Morino Y. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction. Evidence for the presence of a common structure. J. Biol. Chem. 266:1991;7329-7332.
22. ε -(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction Biochemistry. 35:1996;8075-8083.
23. Rosen K.M., Lamperti E.D., Villa-Komaroff L. Optimizing the Northern blot procedure. Biotechniques. 8:1990;398-403.
24. Slater T.F., Sawyer B.C. The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vitro. General features of the systems used. Biochem. J. 123:1971;805-814.
25. Peiro C., Lafuente N., Matesanz N., Cercas E., Llergo J.L., Callejo S., Rodriguez-Manas L., Sanchez-Ferrer C.F. High glucose induces cell death of cultured human aortic smooth muscle cells through the formation of hydrogen peroxide. Br. J. Pharmacol. 133:2001;967-974.
26. Graier W.F., Grubenthal I., Dittrich P., Wascher T.C., Kostner G.M. Intracellular mechanism of high D-glucose-induced modulation of vascular cell proliferation. Eur. J. Pharmacol. 294:1995;221-229.
27. Sakuma H., Yamamoto M., Okumura M., Kojima T., Maruyama T., Yasuda K. High glucose inhibits apoptosis in human coronary artery smooth muscle cells by increasing bcl-xL and bfl-1/A1. Am. J. Physiol. Cell Physiol. 283:2002;C422-C428.
28. Zyzak D.V., Richardson J.M., Thorpe S.R., Baynes J.W. Formation of reactive intermediates from Amadori compounds under physiological conditions. Arch. Biochem. Biophys. 316:1995;547-554.
29. Lal S., Szwergold B.S., Taylor A.H., Randall W.C., Kappler F., Wells-Knecht K., Baynes J.W., Brown T.R. Metabolism of fructose-3-phosphate in the diabetic rat lens. Arch. Biochem. Biophys. 318:1995;191-199.
30. Lal S., Randall W.C., Taylor A.H., Kappler F., Walker M., Brown T.R., Szwergold B.S. Fructose-3-phosphate production and polyol pathway metabolism in diabetic rat hearts. Metabolism. 46:1997;1333-1338.
31. Petersen A., Szwergold B.S., Kappler F., Weingarten M., Brown T.R. Identification of sorbitol 3-phosphate and fructose 3-phosphate in normal and diabetic human erythrocytes. J. Biol. Chem. 265:1990;17424-17427.
32. Hamada Y., Odagaki Y., Sakakibara F., Naruse K., Koh N., Hotta N. Effects of an aldose reductase inhibitor on erythrocyte fructose 3-phosphate and sorbitol 3-phosphate levels in diabetic patients. Life Sci. 57:1995;23-29.
33. Pε -(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients Diabetes Care. 23:2000;1539-1544.
34. Higashiyama S., Abraham J.A., Miller J., Fiddes J.C., Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science. 251:1991;936-939.
35. Higashiyama S., Abraham J.A., Klagsbrun M. Heparin-binding EGF-like growth factor synthesis by smooth muscle cells. Horm. Res. 42:1994;9-13.
36. Temizer D.H., Yoshizumi M., Perrella M.A., Susanni E.E., Quertermous T., Lee M.E. Induction of heparin-binding epidermal growth factor-like growth factor mRNA by phorbol ester and angiotensin II in rat aortic smooth muscle cells. J. Biol. Chem. 267:1992;24892-24896.
37. Peoples G.E., Blotnick S., Takahashi K., Freeman M.R., Klagsbrun M., Eberlein T.J. T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role. Proc. Natl. Acad. Sci. USA. 92:1995;6547-6551.
38. Arkonac B.M., Foster L.C., Sibinga N.E., Patterson C., Lai K., Tsai J.C., Lee M.E., Perrella M.A., Haber E. Vascular endothelial growth factor induces heparin-binding epidermal growth factor-like growth factor in vascular endothelial cells. J. Biol. Chem. 273:1998;4400-4405.
39. Raab G., Klagsbrun M. Heparin-binding EGF-like growth factor. Biochim. Biophys. Acta. 1333:1997;F179-F200.
40. Reape T.J., Wilson V.J., Kanczler J.M., Ward J.P., Burnand K.G., Thomas C.R. Detection and cellular localization of heparin-binding epidermal growth factor-like growth factor mRNA and protein in human atherosclerotic tissue. J. Mol. Cell. Cardiol. 29:1997;1639-1648.
41. Nakata A., Miyagawa J., Yamashita S., Nishida M., Tamura R., Yamamori K., Nakamura T., Nozaki S., Kameda-Takemura K., Kawata S., Taniguchi N., Higashiyama S., Matsuzawa Y. Localization of heparin-binding epidermal growth factor-like growth factor in human coronary arteries. Possible roles of HB-EGF in the formation of coronary atherosclerosis. Circulation. 94:1996;2778-2786.
42. Asakawa H., Miyagawa J., Higashiyama S., Goishi K., Hanafusa T., Kuwajima M., Taniguchi N., Matsuzawa Y. High glucose and hyperosmolarity increase heparin-binding epidermal growth factor-like growth factor (HB-EGF) production in cultured human aortic endothelial cells. Cell Biochem. Funct. 14:1996;181-186.
43. Fukuda K., Kawata S., Inui Y., Higashiyama S., Matsuda Y., Igura T., Tamura S., Taniguchi N., Matsuzawa Y. High concentration of glucose increase mitogenic responsiveness to heparin-binding epidermal growth factor-like growth factor in rat vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 17:1997;1962-1968.
44. Vander Jagt D.L., Robinson B., Taylor K.K., Hunsaker L.A. Reduction of trioses by NADPH-dependent aldo-keto reductases. Aldose reductase, methylglyoxal, and diabetic complications. J. Biol. Chem. 267:1992;4364-4369.
45. 2-terminal kinase in rat aortic smooth muscle cells. FASEB J. 15:2001;1472-1474.
46. Miyazaki Y., Shinomura Y., Tsutsui S., Yasunaga Y., Zushi S., Higashiyama S., Taniguchi N., Matsuzawa Y. Oxidative stress increases gene expression of heparin-binding EGF-like growth factor and amphiregulin in cultured rat gastric epithelial cells. Biochem. Biophys. Res. Commun. 226:1996;542-546.
47. Giardino I., Edelstein D., Brownlee M. BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J. Clin. Invest. 97:1996;1422-1428.
48. Abordo E.A., Minhas H.S., Thornalley P.J. Accumulation of α-oxoaldehydes during oxidative stress: a role in cytotoxicity. Biochem. Pharmacol. 58:1999;641-648.
49. +)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J. Clin. Invest. 94:1994;853-859.
50. Chang W.P., Dimitriadis E., Allen T., Dunlop M.E., Cooper M., Larkins R.G. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus. Diabetologia. 34:1991;225-231.
51. Dluz S.M., Higashiyama S., Damm D., Abraham J.A., Klagsbrun M. Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. Induction of mRNA levels and secretion of active mitogen. J. Biol. Chem. 268:1993;18330-18334.